Home > News > Archives > 2009 > Index

2009 News First-in-kind trial examines how diagnostic tests impact patients' later health Dr. Califf named as Distinguished Scientist for 2009 Stimulus bill awards DCRI millions in NIH grants DCRI's Magnus Ohman quoted in US News & World Report about heart attack tests New study helps explain why women have higher mortality rates after heart attack Study provides guidelines for conflict of interest notices DCRI's Eric Peterson quoted in News and Observer on pay-for-performance New genetic discovery identifies which patients likely to benefit from Hepatitis C treatment Study finds competing Hepatitis C treatments offer similar success rates for patients DCRI's Schulman writes editorial on health care reform President Obama quotes DCRI JAMA paper Kramer votes to make Tylenol safer AHA grant awarded for congenital heart defect study Eric Velazquez to co-lead global Center of Excellence Uncertainty about symptoms can impact quality of life for Hepatitis C patients Persistent use of beta blockers associated with heart failure survival DCRI thinktank leads to plan for national Afib registry Study finds new Hepatitis C combination therapy more effective than standard therapy New tool to help assess bleeding risks for certain heart attack patients Get With the Guidelines, Hernandez highlighted in Wall Street Journal Lynda Szczech: 1st woman president of the National Kidney Foundation New editorial on the growing kidney disease epidemic and how to better combat it DCRI's Kevin Schulman addresses ownership of medical information in editorial Late-breaking clinical trial: STICH finds no added quality of life improvement Late-breaking clinical trial: Early ACS results Late-breaking clinical trial: Results of surgical treatment for heart failure Late-breaking clinical trial at ACC: Long term outcomes related to stents DCRI cardiologist stresses value of genomics, other factors to eliminating health disparities PCI mortality data more likely to improve provider quality than inform consumer choice New drug could offer blood clot prevention with less risk of bleeding Income differences no longer contribute to mortality risks for dialysis patients Trial data confirms effects of S. aureus on mortality, costs of dialysis patients Evidence still not dominant driver of clinical practice in cardiology Patients who delay seeking care for heart attacks fare equally well with cheaper, less invasive option DCRI researchers discuss the implications of conducting clinical trials overseas Stroke patients admitted to hospitals during off-hours face greater mortality risk Public policy can impact the types of new research that get funded Resources that offer information on cancer drugs might be outdated New study finds approximately 20% of eligible heart failure patients get defibrillators New study finds Get With the Guidelines program improves stroke outcomes DCRI voluntary financial disclosures highlighted as part of growing trend New study finds beta blockers help many elderly patients with certain type of heart failure New study finds women more likely to experience delays in care following heart attack DCRI cardiologist is lead author for new criteria for angioplasty and heart bypass surgery Evidence-based, non-evidence-based β-blockers have similar effect on HF survival

© 2003-2009 Duke Clinical Research Institute.